Welcome : Guest

Silence Therapeutics Plc (UK) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Silence Therapeutics Plc, which is principally a Drug Development Company. Illustrated with 205 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-43340
Price: $3500
Company Type: Public
Pages: 208
Date: March 2017
Market Data Tables: 205

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Silence Therapeutics Plc’s Sales by Geographic Region Worldwide (2014) in Percentage for Europe and North America......4
Pharmaceuticals......5
Table 2: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......5
Table 3: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......6
Table 4: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......7
Table 5: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......8
Table 6: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......9
Table 7: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......10
Table 8: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......11
Table 9: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......12
Table 10: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......13
Table 11: Research & Development Spending in Pharmaceuticals by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......14
Table 12: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......15
Table 13: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......16
Table 14: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......17
Table 15: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......18
Table 16: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......19
Table 17: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti-Infective, and Others......20
Table 18: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......21
Table 19: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......22
Table 20: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......23
Table 21: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......24
Table 22: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......25
Table 23: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......26
Table 24: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......27
Table 25: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......28
Table 26: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......29
Table 27: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......30
Cancer Drugs......31
Table 28: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......31
Table 29: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......32
Cancer Market......33
Table 30: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......33
Table 31: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......34
Table 32: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......35
Table 33: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......36
Table 34: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......37
Table 35: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......38
Table 36: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......39
Table 37: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......40
Cancer Patients......41
Table 38: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......41
Table 39: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......42
Table 40: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......43
Table 41: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......44
Table 42: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......45
Table 43: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......46
Table 44: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......47
Table 45: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......48
Table 46: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......49
Table 47: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......50
Table 48: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......51
Table 49: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......52
Table 50: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......53
Table 51: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......54
Table 52: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......55
Table 53: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......56
Table 54: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......57
Table 55: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......58
Table 56: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......59
Table 57: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......60
Table 58: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......61
Cervical Cancer......62
Table 59: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......62
Table 60: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......63
Hematological Cancer......64
Table 61: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......64
Skin Cancer......65
Table 62: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......65
Cancer-Associated Mucositis......66
Table 63: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......66
Chronic Myelogenous Leukemia (CML)......67
Table 64: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......67
Multiple Myeloma......68
Table 65: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......68
Table 66: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......69
Drugs......70
Table 67: Drugs Market by Region Worldwide (2015) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......70
Table 68: Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......71
Table 69: Spending on Drugs by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......72
Table 70: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......73
Table 71: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Brand, Generic and Others......74
Table 72: Drugs Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Biotechnology, Conventional and Other Unclassified......75
Table 73: Spending on Medicines by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Australia, Europe, Latin America, North America, and others......76
Table 74: Drug Market by Category in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......77
Table 75: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......78
Table 76: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......79
Table 77: Drugs Market by Category in Brazil (2015) - Percentage Share Breakdown by Volume for Generics and Others......80
Table 78: Drug Distribution Expenditure by Category in Canada (2015) - Percentage Share Breakdown by Value for Out of Pocket, Private Insurers and Public Payers......81
Table 79: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Medical Devices, Over-the-counter Drugs, Prescription Drugs, Traditional Chinese Medicine, and Others......82
Table 80: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Finished Drugs and Intermediate and Bulk Medicine......83
Table 81: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......84
Table 82: Finished Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Antihypertensive Drugs, Digestive System Drugs, Liver Drugs and Others......85
Table 83: Patent Medicines Sales by Drugs in China (2015) - Percentage Share Breakdown by Value for Cardio-Cerebrovascular Drugs, Digestive System Drugs, Drugs for Deoplastic Diseases, Gynecological Drugs, Musculoskeletal Drugs, Nervous System Drugs, Respiratory System Drugs, Urinary System Drugs and Others......86
Table 84: Drugs Market by Category in France (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......87
Table 85: Formulations Sales by Category in India (2015) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......88
Table 86: Drugs Market by Sector in Greece (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......89
Table 87: Ethical Drugs Revenues by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generic, Licensed and Unbranded Generic......90
Table 88: Drugs Market by Category in Italy (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......91
Table 89: Drugs Market by Category in Singapore (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......92
Table 90: Prescription Drugs Market in the US (2014) in US$ Million......93
Table 91: Critical Shortage Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectable, Orals, and Others......94
Table 92: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......95
Table 93: Critical Shortage Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Brand, Branded Generic, Generic, and Other Branded Generic......96
Table 94: Spending on Drugs by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Drugs and Traditional Drugs......97
Table 95: Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Non-specialty and Specialty......98
Table 96: Drugs Sales by Type in the US (2015) - Percentage Share Breakdown by Value for Cefdinir, Cephalexin, Cofactor and Other......99
Table 97: A-2 Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Generic Doxycycline, Generic Minocycline, Generic Tetracycline, and Others......100
Table 98: Spending on Medicines by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Pharmaceuticals and Traditional Pharmaceuticals......101
Table 99: Spending on Medicines by Product in the US (2015) - Percentage Share Breakdown by Value for Injectable, Oral and Other Forms......102
Table 100: Spending on Medicines by Segment in the US (2015) - Percentage Share Breakdown by Value for Biologics and Small-Molecules......103
Table 101: Spending on Medicines by Source in the US (2015) - Percentage Share Breakdown by Value for Non-Retail and Retail......104
Table 102: Spending on Medicines by Type in the US (2015) - Percentage Share Breakdown by Value for Branded Generics, Brands and Unbranded Generics......105
Drugs of Abuse Testing (DOA) Testing......106
Table 103: Drugs of Abuse Testing (DOA) Testing by Technology Worldwide (2015) - Percentage Market Share Breakdown by Value for Heterogeneous, Homogenous, and POC/Rapid......106
Epilepsy Drugs......107
Table 104: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......107
Vaccines......108
Table 105: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......108
Diabetes......109
Table 106: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......109
Table 107: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......110
Table 108: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......111
Table 109: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......112
Table 110: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......113
Table 111: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......114
Table 112: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......115
Table 113: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......116
Table 114: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......117
Table 115: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......118
Diabetes Drugs......119
Table 116: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......119
Table 117: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......120
Table 118: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......121
Table 119: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......122
Table 120: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......123
Table 121: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......124
Table 122: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......125
Table 123: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......126
Table 124: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......127
Table 125: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......128
Table 126: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......129
Non-Insulin Anti-Diabetic Drugs......130
Table 127: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......130
Diabetic Macular Edema (DME)......131
Table 128: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......131
Table 129: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2014) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......132
Insulin......133
Table 130: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......133
Table 131: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......134
Table 132: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......135
Table 133: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......136
Table 134: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......137
DPP-4 Inhibitors......138
Table 135: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......138
Table 136: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......139
Table 137: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......140
Table 138: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......141
Table 139: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......142
Table 140: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......143
DPP-4 type Diabetes Drugs......144
Table 141: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......144
Infectious Disease Drugs......145
Table 142: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......145
Table 143: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......146
Table 144: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......147
Table 145: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Other......148
Table 146: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......149
Table 147: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......150
Table 148: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......151
Table 149: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......152
Preclinical Pharmaceuticals......153
Table 150: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......153
Prescription Pharmaceuticals......154
Table 151: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......154
Table 152: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......155
Table 153: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......156
Table 154: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......157
Table 155: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......158
RadioPharmaceuticals......159
Table 156: Market Shares of Leading Radiopharmaceutical Drug Providers in the US (2015) - Percentage Breakdown by Value for Amersham Plc, Cardinal Health, Inc., Independents, and Triad Healthcare Inc.......159
Table 157: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......160
Table 158: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......161
Table 159: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......162
Table 160: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......163
Table 161: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......164
Breast Cancer Drugs......165
Table 162: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......165
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......166
Table 163: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......166
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......167
Table 164: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......167
Table 165: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......168
Table 166: Market Shares of Leading Drug Distributors Worldwide (2014) - Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......169
Table 167: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......170
Table 168: Market Shares of Leading Domestic Drugs Manufacturers in Vietnam (2015) - Percentage Share Breakdown by Volume for DHG Pharmaceutical JSC, Traphaco Joint Stock Company and Others......171
Vaccines......172
Table 169: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......172
Diphtheria and Tetanus Vaccines......173
Table 170: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......173
Hepatitis A Vaccines......174
Table 171: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......174
Hepatitis B (Recombinant) Vaccines......175
Table 172: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......175
Hepatitis A and Typhoid Polysaccharide Vaccines......176
Table 173: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......176
Human Papillomavirus Vaccines......177
Table 174: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......177
Human Rotavirus Vaccines......178
Table 175: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......178
Influenza Vaccines......179
Table 176: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......179
Measles, Mumps and Rubella Vaccines......180
Table 177: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......180
Tetanus Toxoid, reduced Diphthera Vaccines......181
Table 178: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......181
Typhoid Vaccines......182
Table 179: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......182
Varilrix Vaccines......183
Table 180: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......183
Table 181: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......184
Table 182: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......185
Table 183: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......186
Table 184: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......187
Table 185: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......188
Table 186: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......189
Table 187: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......190
Table 188: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......191
Table 189: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......192
Table 190: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......193
Table 191: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......194
Table 192: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......195
Table 193: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......196
Second-Generation Insulin......197
Table 194: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......197
Third-Generation Insulin......198
Table 195: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......198
Human Insulin......199
Table 196: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......199
Table 197: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......200
Table 198: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......201
Table 199: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......202
Sitagliptin/Metformin......203
Table 200: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......203
Table 201: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......204
Table 202: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......205
Table 203: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......206
Metformin......207
Table 204: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......207
Table 205: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......208